Best Funds
Closed end funds are similar to exchange traded funds. They may offer value for investors though yield and discounted value from its NAV (Net Asset Value). These funds are traded like stock.These best performing closed end funds are sorted based on its year to date return in 2015 (up to July, 13 2015). You may find other fund review information: expense ratio, fund’s NAV, management, objective, yield, top holdings, etc.
Top 14 closed end funds in 2015 are:
- Cornerstone Total Return (CRF)
- Tekla Life Sciences Investors (HQL)
- Tekla Healthcare Investors (HQH)
- Cornerstone Strategic Value (CLM)
- JH Financial Opportunities (BTO)
- Aberdeen Japan Equity Fund (JEQ)
- Japan Smaller Capitalization (JOF)
- New Ireland Fund (IRL)
- Herzfeld Caribbean Basin (CUBA)
- EV Tax-Managed Global Buy Write Opportunities (ETW)
- BlackRock International Growth & Income (BGY)
- Aberdeen Israel (ISL)
- New Germany Fund (GF)
- Apollo Senior Floating Rate (AFT)
Cornerstone Total Return Fund
This Cornerstone Total Return Fund invests mainly in common stocks, preferred stocks and convertible stock. It has $73 million of assets. The fund manager is Ralph W. Bradshaw. The current yield is 15.82%. Its share price is $24.71.More: Best 15 Municipal Bond Closed End Funds 2015
Morningstar has ranked this top closed end fund with 4 star rating. In 2015, it has YTD return of 40.89%. It has returned 26.55% over the past 3 year, and 17.20% over the past 5 year. Top 3 stocks are Apple Inc, Exxon Mobil Corporation, and Wal-Mart Stores Inc.
Tekla Life Sciences Investors Fund
As one of the top 14 closed end funds in 2015, Tekla Life Sciences Investors Fund utilizes its assets to purchase stocks of life sciences companies. It is popular among investors. It has total assets of $576 million. The expense fee is 1.33% per year.More: Top 10 Best Closed End Funds 2012 & 2013
In 2015, it has year to date return of 17.72%. The average 3 year return is 36.48%. Top 5 stocks are Celgene Corporation, Gilead Sciences Inc, Biogen Idec Inc, Regeneron Pharmaceuticals Inc, and Incyte Corporation.
Fund Returns
| No | Fund Name | Ticker | Category | YTD Return % |
|---|---|---|---|---|
| 1 | Cornerstone Total Return | CRF | US Equity-General Equity | 40.72% |
| 2 | Tekla Life Sciences Investors | HQL | US Equity-Health/Biotech | 20.77% |
| 3 | Tekla Healthcare Investors | HQH | US Equity-Health/Biotech | 19.60% |
| 4 | Cornerstone Strategic Value | CLM | US Equity-General Equity | 18.79% |
| 5 | JH Financial Opportunities | BTO | US Equity-Finance | 17.96% |
| 6 | Aberdeen Japan Equity Fund | JEQ | Non-US/Other-Asia Equity | 17.13% |
| 7 | Japan Smaller Capitalization | JOF | Non-US/Other-Asia Equity | 17.06% |
| 8 | New Ireland Fund | IRL | Non-US/Other-Other Non-US Equity | 14.22% |
| 9 | Herzfeld Caribbean Basin | CUBA | Non-US/Other-Latin American Equity | 13.61% |
| 10 | EV Tax-Managed Glb B-W Opps | ETW | US Equity-Covered Call | 13.54% |
| 11 | BlackRock Intern'l Grth & Inc | BGY | US Equity-Covered Call | 12.87% |
| 12 | Aberdeen Israel | ISL | Non-US/Other-Other Non-US Equity | 12.39% |
| 13 | New Germany Fund | GF | Non-US/Other-Other Non-US Equity | 12.22% |
| 14 | Apollo Senior Floating Rate | AFT | Taxable Income-Senior Loan | 11.83% |
No comments:
Post a Comment